Why has Evidation Health's data sharing opt-in rate for pharmaceutical research partnerships declined by 10% this quarter?

Introduction

Evidation Health's 10% decline in data sharing opt-in rates for pharmaceutical research partnerships this quarter is a concerning trend that requires immediate attention. This issue directly impacts the company's ability to provide valuable health insights to pharmaceutical partners, potentially affecting revenue and future collaborations. I'll approach this problem systematically, focusing on identifying the root cause, validating hypotheses, and developing both short-term and long-term solutions.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be seasonal factors at play. Has this decline been observed in previous years during the same quarter?

Why it matters: Seasonal patterns could explain the fluctuation and inform our approach. Expected answer: No, this decline is unusual for this quarter. Impact on approach: If seasonal, we'd focus on cyclical strategies; if not, we'd investigate recent changes.

• Considering user segments, I'm curious about the demographics. Has the decline been uniform across all user groups, or are certain segments more affected?

Why it matters: Identifying specific affected groups could pinpoint targeted issues. Expected answer: The decline is more pronounced in users aged 45-60. Impact on approach: We'd focus on understanding the needs and concerns of this particular age group.

• Thinking about recent changes, have there been any updates to the data sharing consent process or user interface in the last quarter?

Why it matters: UI/UX changes could significantly impact user behavior and opt-in rates. Expected answer: A minor update to the consent form was implemented last month. Impact on approach: We'd closely examine the impact of this change on user comprehension and willingness to opt-in.

• Regarding external factors, has there been any recent media coverage or public discourse about data privacy in health tech that might have influenced user perception?

Why it matters: External narratives can shape user trust and willingness to share data. Expected answer: There was a high-profile data breach in a similar health tech company last month. Impact on approach: We'd need to address potential trust issues and reinforce our security measures.